Agile Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AGRX for the last quarter is 3.62 M USD, and it's 45.74% lower compared to the previous quarter. The net income of Q4 23 is -4.47 M USD.